AUPH Aurinia Pharmaceuticals Inc.
Pharmaceutical Preparations · Nasdaq · SEC EDGAR official
Market Value*
$1.00B
Revenue (FY)
$283.06M 2025-12-31
Net Income (FY)
$287.20M
P/E (float-based)
3.5
Pharmaceutical Preparations · Nasdaq · SEC EDGAR official